1H NMR metabolomics study of age profiling in children

NMR in Biomedicine

Volumn 22, Issue 8, 2009, Pages 826-833

  Gu, Haiwei ^a   Pan, Zhengzheng ^a   Xi, Bowei ^b   Hainline, Bryan E ^c   Shanaiah, Narasimhamurthy ^a   Asiago, Vincent ^a   Gowda, G A Nagana ^a   Raftery, Daniel ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age; Human urine; Metabolite profiling; Metabolomics; Metabonomics; Nuclear magnetic resonance; Orthogonal signal correction; Principal component analysis

Indexed keywords

HUMAN URINE; METABOLITE PROFILING; METABOLOMICS; METABONOMICS; ORTHOGONAL SIGNAL CORRECTION;

ACETONE; BIOMOLECULES; BODY FLUIDS; METABOLISM; METABOLITES; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RESONANCE;

PRINCIPAL COMPONENT ANALYSIS;

ACETONE; BETAINE; CITRIC ACID; CREATINE; CREATININE; GLYCINE; SUCCINIC ACID; BIOLOGICAL MARKER;

AGE DETERMINATION; AGE DISTRIBUTION; AGING; ARTICLE; CHILD; CONTROLLED STUDY; HUMAN; INFANT; METABOLIC RATE; METABOLITE; METABOLOMICS; NEWBORN; PARTIAL LEAST SQUARES REGRESSION; PRESCHOOL CHILD; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; STATISTICAL ANALYSIS; URINALYSIS; AGE; METABOLOME; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE; PHYSIOLOGY; URINE;

AGE FACTORS; AGING; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CREATINE; HUMANS; INFANT; INFANT, NEWBORN; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PRINCIPAL COMPONENT ANALYSIS;

EID: 70649089393     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1395     Document Type: Article

References (66)

1. Jackson SHD, Weale MR, Weale RA. Biological age - what is it and can it be measured? Arch. Gerontol. Geriatr. 2003; 36: 103-115.
2. Ingram DK, Nakamura E, Smucny D, Roth GS, Lane MA. Strategy for identifying biomarkers of aging in long-lived species. Exp. Gerontol. 2001; 36: 1025-1034.
3. Randerath K, Zhou GD, Hart RW, Turturro A, Randerath E. Biomarkers of aging-correlation of DNA I-compound levels with median lifespan of calorically restricted and ad libitum fed rats and mice. Mutat. Res. 1993; 295: 247-263.
4. Vranckx R, Savu L, Lambert N, Vermeil-De-Conchard G, Grosse R, Mourey MS, Corman B. Plasma proteins as biomarkers of the aging process. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1995; 37: 536-548.
5. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, Saude EJ, Lix B, Adamko DJ, Shah S, Greiner R, Sykers BD, Marrie TJ. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal. Chem. 2007; 79: 6995-7004.
6. Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET. Genderrelated and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008; 21: 195-207.
7. Kochhar S, Jacobs DM, Ramadan Z, Berruex F, Fuerhoz A, Fay LB. Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal. Biochem. 2006; 352: 274-281.
8. Kristal BS, Shurubor YI, Kaddurah-Daouk R, Matson WR. Metabolomics in the study of aging and caloric restriction. Methods Mol. Biol. 2007; 371: 393-409.
9. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discovery 2002; 1: 153-161.
10. Allen J, Davey HM, Broadhurst D, Heald JK, Rowland JJ, Oliver SG, Kell DB. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat. Biotechnol. 2003; 21: 692-696.
11. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, Provost JP, Net JL, Baker D, Walley RJ, Everett JR, Nicholson JK. Pharmacometabonomic phenotyping and personalized drug treatment. Nature 2006; 440: 1073-1077.
12. 1H-NMR- based metabonomics. Int. J. Cancer 2005; 113: 782-788.
13. Sandusky P, Raftery D. Use of selective TOCSY NMR experiments for quantifying minor components in complex mixtures: Application to the metabonomics of amino acids in honey. Anal. Chem. 2005; 77: 2455-2463.
14. Pan Z, Gu H, Talaty N, Chen H, Shanaiah N, Hainline BE, Cooks RG, Raftery D. Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism. Anal. Bioanal. Chem. 2007; 387: 539-549.
15. Beger RD, Schnackenberg LK, Holland RD, Li DH, Dragan Y. Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma. Metabolomics 2006; 2: 125-134. (Pubitemid 44473571)
16. 1H-NMR-based metabolomics. Expert Rev. Mol. Diagn. 2006; 6: 717-731.
17. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC, Mitchell SC, Holmes E, McCarthy MI, Scott J, Gauguier D, Nicholoson JK. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Nat. Acad. Sci. U.S.A. 2006; 103: 12511-12516.
18. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol. 2002; 48: 155-171.
19. Gowda GAN, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. Metabolomics-based methods for early disease diagnostics: a review. Exp. Rev. Mol. Diagn. 2008; 8: 617-633.
20. 1H NMR study of the effects of sample contamination in the metabolomic analysis of mouse urine. J. Pharm. Biomed. Anal. 2007; 45: 134-140.
21. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181-1189.
22. Pan Z, Raftery D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal. Bioanal. Chem. 2007; 387: 525-527.
23. van-der-Greef J, Smilde AK. Symbiosis of chemometrics and metabolomics: past, present, and future. J. Chemom. 2005; 19: 376-386.
24. Chen H, Pan Z, Talaty N, Raftery D, Cooks RG. Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation. Rapid Commun. Mass Spectrom. 2006; 20: 1577-1584.
25. Crockford DJ, Holmes E, Lindon JC, Plumb RS, Zirah S, Bruce SJ, Rainville P, Stumpf CL, Nicholosn JK. Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: Application in metabonomic toxicology studies. Anal. Chem. 2006; 78: 363-371.
26. Engelke UFH, Liebrand-Van-Sambeek MLF, De-Jong JGN, Leroy JG, Morava E, Smeitink JAM, Wevers RA. N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. Clin. Chem. 2004; 50: 58-66.
27. Zhang S, Gowda GAN, Asiago V, Shanaiah N, Barbas C, Raftery D. Quantitative NMR-based metabolic profiling in diabetic rats. Anal. Biochem. 2008; 383: 76-84.
28. Constantinou MA, Papakonstantinou E, Benaki D, Spraul M, Shulpis K, Koupparis MA, Mikros E. Application of nuclear magnetic resonance spectroscopy combined with principal component analysis in detecting inborn errors of metabolism using blood spots: a metabonomic approach. Anal. Chim. Acta 2004; 511: 303-312.
29. Assfalg M, Bertini I, Colangiuli D, Luchinat C, Shafer H, Schutz B, Spraul M. Evidence of different metabolic phenotypes in humans. Proc. Nat. Acad. Sci. U.S.A. 2008; 105: 1420-1424.
30. Phipps AN, Stewart J, Wright B, Wilson ID. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 1998; 28: 527-537.
31. Ramadan Z, Jacobs D, Grigorov M, Kochhar S. Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms. Talanta 2006; 68: 1683-1691. (Pubitemid 43144528)
32. Remer T, Boye KR, Hartmann MF, Wudy SA. Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. J. Clin. Endocrinol. Metab. 2005; 90: 2015-2021.
33. Valongo C, Cardoso ML, Domingues P, Almeida L, Verhoeven N, Salomons G, Jakobs C, Vilarinho L. Age related reference values for urine creatine and guanidinoacetic acid concentration in children and adolescents by gas chromatography-mass spectrometry. Clin. Chim. Acta 2004; 348: 155-161.
34. Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, van-der-Ouderaa F, Bingham S, Cross AJ, Nicholson JK. Susceptibility of human metabolic phenotypes to dietary modulation. J. Proteome Res. 2006; 5: 2780-2788.
35. Lindon JC, Holmes E, Nicholson JK. Pattern recognition methods and applications in biomedical magnetic resonance. Prog. Nucl. Magn. Reson. Spectrosc. 2001; 39: 1-40.
36. 1H NMR and HPLC-TOF MS. Mol. Biosyst. 2005; 1: 166-175.
37. Williams RE, Lenz EM, Rantalainen M, Willson ID. The comparative metabonomics of age-related changes in the urinary composition of male Wistar-derived and Zucker (fa/fa) obese rats. Mol. Biosyst. 2006; 2: 193-202.
38. Bell JD, Sadler PJ, Morris VC, Levander OA. Effect of aging and diet on proton NMR spectra of rat urine. Magn. Reson. Med. 1991; 17: 414-422.
39. Wold S, Antti H, Lindgren F, Ohman J. Orthogonal signal correction of near-infrared spectra. Chemom. Intell. Lab. Syst. 1998; 44: 175-185.
40. Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemom. 2002; 16: 119-128.
41. Gavaghan CL, Wilson ID, Nicholson JK. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett. 2002; 530: 191-196.
42. Rantalainen M, Cloarec O, Beckonert O, Wilson ID, Jackson D, Tonge R, Rowlinson R, Rayner S, Nickson J, Wilkinson RW, Mills JD, Trygg J, Nicholson JK, Holmes E. Statistically integrated metabonomicproteomic studies on a human prostate cancer xenograft model in mice. J. Proteome Res. 2006; 5: 2642-2655. (Pubitemid 44595166)
43. 1H NMR spectra. Acta Chim. Sinica 2007; 65: 152-158.
44. Plumb RS, Granger JH, Stumpf CL, Johnson KA, Smith BW, Gaulitz S, Wilson ID, Castro-Perez J. A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 2005; 130: 844-849. (Pubitemid 40880105)
45. Moser VC, Padilla S, Hunter DL, Marshall RS, McDaniel KL, Phillips PM. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol. Appl. Pharmacol. 1998; 149: 107-119.
46. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the US population: Implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005; 113: 192-200.
47. Fan WMT. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog. Nucl. Magn. Reson. Spectrosc. 1996; 28: 161-219.
48. 1H NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine. Anal. Chim. Acta 2005; 542: 169-177.
49. Nicholls AW, Mortishire-Smith RJ, Nicholson JK. NMR spectroscopicbased metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 2003; 16: 1395-1404.
50. Griffin JL, Walker LA, Garrod S, Holmes E, Shore RF, Nicholson JK. NMR spectroscopy based metabonomic studies on the comparative biochemistry of the kidney and urine of the bank vole (Clethrionomys glareolus), wood mouse (Apodemus sylvaticus), white toothed shrew (Crocidura suaveolens) and the laboratory rat. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 2000; 127: 357-367.
51. 1H NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3. Anal. Biochem. 2002; 301: 1-7.
52. 13C CP/ MAS NMR spectroscopic characterization of softwood kraft pulp. Magn. Reson. Chem. 2001; 39: 267-275.
53. Eriksson L, Antti H, Gottfries J, Holmes E, Johansson E, Lindgren F, Long I, Lundstedt T, Trygg J, Wold S. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal. Bioanal. Chem. 2004; 380: 419-429.
54. Westerhuis JA, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, van-Velzen EJJ, van-Duijnhoven JPM, van-Dorsten FA. Assessment of PLSDA cross validation. Metabolomics 2008; 4: 81-89.
55. Aoyama H, Kamiyama Y, Ukikusa M, Ozawa K. Clinical significance of hippurate synthesizing capacity in surgical patients with liver disease: a metabolic tolerance test. J. Lab. Clin. Med. 1986; 108: 456-460.
56. Nelson DL, Cox MM. Lehninger Principles of Biochemistry.W.H. Freeman and Company: New York, 2005.
57. Dos Santos JP, Iobbi-Nivol C, Couillault C, Giordano G, Mejean V. Molecular analysis of the trimethylamine N-oxide (TMAO) reductase respiratory system from a Shewanella species. J. Mol. Biol. 1998; 284: 421-433.
58. Athawale MV, Dordick JS, Garde S. Osmolyte trimethylamine-N-oxide does not affect the strength of hydrophobic interactions: origin of osmolyte compatibility. Biophys. J. 2005; 89: 858-866. (Pubitemid 41098972)
59. Brittain T. Functional protection of human haemoglobin against protein dissociation. IUBMB Life 2000; 50: 131-134.
60. Craig SAS. Betaine in human nutrition. Am. J. Clin. Nutr. 2004; 80: 539-549.
61. Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OC, Burnham WM. Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann. Neurology 2003; 54: 219-226. (Pubitemid 36909620)
62. Berg MJ, Tymoczko LJ, Stryer L. Biochemistry. W.H. Freeman and Company: New York, 2001.
63. Stambaugh R, Davidson DT Jr, Elkinston JR. Variation of excretion of certain amino acids with age. Clin. Chem. 1963; 9(2): 210-216.
64. Guneral F, Bachmann C. Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin. Chem. 1994; 40(6): 862-868.
65. Heymsfield SB, Lohman TG, Wang Z, Going SB. Human Body Composition. Human Kinetics Publishers: Champaign, Illinois, 2005.
66. Greenhaff PL. The nutritional biochemistry of creatine. J. Nutr. Biochem. 1997; 8: 610-618.